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ABSTRACT
Stroke is a leading cause of long term disability in the United States. The therapeutic
benefits of intravenous thrombolytics is time dependent in an acute ischemic stroke patient and is
an important determinant of 90 day and one year functional outcomes. This study investigated
areas in the stroke alert process of a community based primary stroke care center that resulted in
the delay of administration of thrombolytics within 60 minutes of an acute ischemic stroke
patient's arrival to the emergency room. A retrospective descriptive design was utilized and chart
reviews were done on 40 patients that received thrombolytics in the emergency room. Patient
characteristics and time variables associated with the various steps in the stroke alert process
were extracted. Findings showed that only 7.5% of the patients received thrombolytics within the
recommended 60 minutes, with the longest time interval associated with time from arrival to the
emergency room to time of evaluation by teleneurologist. There were no significant differences
in the characteristics of patients who received thrombolytics within 60 minutes and those patients
that received thrombolytics after 60 minutes. Recommendations were made for changes in
organizational and practice strategies to improve timely administration, and for future research
involving the effects of quality improvement initiatives.

iii

ACKNOWLEDGMENTS
I would like to sincerely thank and acknowledge my committee members for their time,
expertise and support in helping me complete my thesis. I would like to thank Dr Ullah, for
agreeing to be on my committee and taking time out of his busy schedule to help me. I would
like to thank Dr Chase whose encouragement since my first class with her made me believe the
end was attainable. Her guidance helped me narrow done my topic and despite all the projects
she had going on, she agreed to be on my committee. Her guidance in helping me to clarify and
refine my writing has been so valuable. I would like to express my sincere gratitude to Dr
Talbert, my committee chair, for making the completion of this study a reality. His assistance in
the statistical analysis and completion of the results has been a tremendous help. Dr Talbert's
encouragement, positive feedbacks, corrections and practical attitude , I would be so ever
grateful for. I would also like to acknowledge my husband for being my biggest supporter and
encourager throughout the completion of my thesis and my entire study. Above all, I would like
to thank God, whose unmerited favor in my life has been my strength and hope throughout my
studies.

iv

TABLE OF CONTENTS
LIST OF FIGURES ...................................................................................................................... vii
LIST OF TABLES ....................................................................................................................... viii
CHAPTER 1: THE PROBLEM...................................................................................................... 1
Introduction ................................................................................................................................. 1
Significance ................................................................................................................................. 2
Contraindication to tPA administration ................................................................................... 3
Benefits of early administration of tPA ................................................................................... 3
Organizational guidelines ........................................................................................................ 5
Purpose of the Study ................................................................................................................... 6
Research Questions ..................................................................................................................... 6
CHAPTER 2: REVIEW OF LITERATURE .................................................................................. 7
Stroke Development .................................................................................................................... 7
Evaluation and Diagnosis of Acute Ischemic Stroke .................................................................. 8
Initial Management of Patients with Acute Ischemic Stroke .................................................... 13
Extension of thrombolytic treatment from 3 to 4.5 hours ..................................................... 14
Intravenous thrombolytic administration............................................................................... 15
The ‘Golden Hour’ for Stroke Thrombolysis ............................................................................ 16
Benefits of Early Stroke Thrombolysis ..................................................................................... 17
Prehospital Delays to Early Stroke Thrombolysis .................................................................... 22
Inhospital Delays to Early Stroke Thrombolysis ...................................................................... 23
Summary ................................................................................................................................... 26
CHAPTER 3: METHODS ............................................................................................................ 27
Setting........................................................................................................................................ 27
Sample Criteria and Method of Data Collection ....................................................................... 27
Protection of Human Subjects ................................................................................................... 28
Study Design ............................................................................................................................. 28
Procedures ................................................................................................................................. 31
v

Statistical Analysis .................................................................................................................... 33
CHAPTER 4: RESULTS .............................................................................................................. 35
CHAPTER 5: DISCUSSIONS ..................................................................................................... 44
Recommendations ..................................................................................................................... 47
Organizational Strategies ....................................................................................................... 48
Practice Strategies.................................................................................................................. 49
Limitations ................................................................................................................................ 54
Future Research ......................................................................................................................... 54
Summary ................................................................................................................................... 54
APPENDIX A: CRITERIA FOR PRIMARY STROKE CENTER CERTIFICATION .............. 56
APPENDIX B: HEALTHCARE FACILITY INSTITUTIONAL REVIEW BOARD LETTER
OF APPROVAL ........................................................................................................................... 61
LIST OF REFERENCES .............................................................................................................. 64

vi

LIST OF FIGURES
Figure 1: Ischemic Stroke Alert Process ....................................................................................... 30
Figure 2: Number of Patients and Time Interval to tPA Administration ...................................... 36
Figure 3: Percentages of Door to Time tPA given for the Entire Group of Patients .................... 37
Figure 4: Comparison of Time to tPA Administration against severity of NIHSS score ............. 40
Figure 5: Comparison of Onset of Symptoms to Door and Door to tPA Administration Time
Interval .......................................................................................................................................... 43

vii

LIST OF TABLES
Table 1: Modified Rankin Scale ................................................................................................... 10
Table 2: National Institute of Health Stroke Scale ....................................................................... 11
Table 3 : Synthesis of Articles related to Early tPA Administration ............................................ 18
Table 4: Sample Stroke Alert Time Log ....................................................................................... 29
Table 5: Threats to Validity .......................................................................................................... 32
Table 6: Comparison of Characteristics of Ischemic Stroke Patients with Door to tPA time of
Greater than 60 Minutes and those Less than 60 Minutes ............................................................ 39
Table 7: Time Intervals Associated with the Acute Stroke Alert Care Process ........................... 42
Table 8: Revised Stroke Alert Time Log ...................................................................................... 53

viii

CHAPTER 1: THE PROBLEM
Introduction
Stroke is a major healthcare problem and is the leading cause of long term functional
impairment in the United States, leaving 15% to 30 % of its victims permanently disabled and
approximately 20% still requiring rehabilitative care at 3 months post stroke (Roger, Go, LloydJones, Adams, et al., 2011). With someone suffering from a stroke every 40 seconds (American
Heart Association, 2010), its impact on health and the economy is staggering. It is estimated that
795,000 individuals suffer from a first time stroke or a recurrence each year, with a current
stroke survivor membership of 6.4 million Americans (Roger, Go, Lloyd-Jones, Adams, et al.,
2011). Stroke is not only a sudden life altering event in the life of a stroke patient, but it also
leaves a heavy toll on family members and care givers. In a survey of preferences of persons at
an increased risk of stroke, greater than 45% of the participants considered stroke to be a worse
outcome than death (Samsa, Matchar, Goldstein, Bonito, et al., 1998). Moreover, the economic
impact is devastating with loss of earning being the biggest cost contributor, with a total
projected cost of stroke between 2005 to 2050 estimated to be $1.52 trillion for whites, $379
billion for blacks, and $313 billion for Hispanics (Brown, Boden-Albala, Langa et al., 2006). In
2010, the cost of stroke care, both direct and indirect costs, was $73.7 billion (Roger, Go, LloydJones, Adams, et al., 2011).
Mortality data released in 2008 revealed that stroke had declined from being the third
leading cause of death in the United States to the fourth leading cause of death, after heart
disease, cancer and chronic lower respiratory diseases (Center for Disease Control and
Prevention [CDC], 2011). Though this statistic is an important reduction signifying the efforts
1

and progress in the prevention and treatment of cerebrovascular diseases, the need to reduce the
burden of post stroke disability with its incalculable human cost and surmounting economic costs
remains (Towfighi & Saver, 2011).

Significance
Strokes primarily fall into three main categories, with ischemic strokes accounting for
87% of all strokes, intracerebral hemorrhage for 10% and subarachnoid hemorrhage strokes for
3% (Roger, Go, Lloyd-Jones, Adams, et al., 2011). Depending on the extent of brain damage,
individuals suffering from stroke can experience altered skills of perception, sensation, intellect
and movement, skills that they have mastered over a lifetime. The main treatment objective for
an individual who has suffered an ischemic stroke is to reinstate the cerebral blood flow as
quickly as possible after an arterial occlusion, in order to decrease damage to viable brain tissue.
The use of intravenous recombinant tissue plasminogen activator (tPA) has
revolutionized acute ischemic stroke treatment and remains the first line choice of therapy. It is
the only approved drug by the Food and Drug Administration (FDA) for the treating acute
ischemic stroke (Adams, del Zoppo, Alberts, Bhatt, et al., 2007). However, tPA benefits
diminish with each passing hour after initial stroke symptoms. Improved outcomes have been
observed if tPA is administered within the first three hours of stroke onset (Adams, del Zoppo,
Alberts, Bhatt, et al., 2007). After completing a systematic review of current studies, a scientific
advisory statement was issued by the American Heart Association and American Stroke
Association (AHA/ASA) recommending the use of tPA up to 4.5 hours from the initial onset of
symptoms of an acute ischemic stroke, for eligible patients without contraindications (Del
2

Zoppo, Saver, Jauch, & Adams, 2009). The evidence clearly states that early tPA administration
is imperative.

Contraindication to tPA administration
Some of the absolute contraindication to tPA administration include uncontrolled systolic
blood pressure greater than 185 mm HG or diastolic blood pressure greater than 110 mm Hg in
spite of repeated treatment, acute trauma or active bleeding, an arterial puncture at an
incompressible site within the past week, clinical presentation suggesting subarachnoid
hemorrhage, seizure with postictal neurological impairment, platelet count less than
100,000/mm3, prothrombin time of greater than 15, known arteriovenous malformation, head
trauma or stroke in the previous three months, and surgery in the past two weeks (Rivera-Bou,
Cabanas, & Villanueva, 2011; Adams, del Zoppo, Alberts, Bhatt, et al., 2007). In order to be
eligible for tPA administration, the neurological signs should not be minor, isolated, nor should it
clear spontaneously (Adams, del Zoppo, Alberts, Bhatt, et al., 2007).

Benefits of early administration of tPA
Ischemic stroke is a treatable neuroemergency, but every minute of delayed therapy may
have adverse consequences. This was emphasized by the American Stroke Association in their
slogan, “Time lost is brain lost”. Using quantitative neurostereology and stroke neuroimaging,
Saver (2006) calculated the amount of brain lost per unit time during an acute ischemic stroke.
During the evolution of an average non lacunar ischemic stroke (10 hours), every untreated
minute of a large vessel ischemic stroke results in the loss of 7 miles of axonal fibers, 1.9 million
neurons, and 13.8 billion synapses (Saver, 2006).
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The therapeutic benefits of tPA decreases with time, with no significant benefit identified
after 4.5 hours from the onset of symptoms of an acute ischemic stroke. An analysis of data from
six large randomized tPA trials showed a strong association between early treatment and
favorable functional outcome (Hacke, Donnan, Fieschi, Kaste, et al., 2004). The odds of a
favorable 3 month outcome increased as onset of stroke to treatment time decreased (p=0·005).
The odds ratio of a favorable outcome for patients treated with tPA within 90 minutes when
compared with controls was 2·81 (1·75–4·50) and was 1·55 (1·12–2·15) for those treated within
91 to 180 minutes (Hacke, Donnan, Fieschi, Kaste, et al., 2004). The National Institute of
Neurological Disorders and Stroke (NINDS) tPA Stroke Study showed that patients treated
within 90 minutes from ischemic stroke onset have an increased odds of improvement at 24
hours and a favorable functional outcome at 3 months when compared to patients treated from 91
minutes to 180 minutes after the onset of stroke (Marler, Tilley, Lu, Brott, et al., 2000). The
adjusted OR (95% CI) for a favorable 3 month outcome associated with tPA was 2.11 (1.33 to
3.35) within 90 minutes and 1.69 (1.09 to 2.62) when given between 91 to 180 minutes.
Analysis of pooled data from six major intravenous tPA stroke trials showed that tPA
therapy was associated with more benefit than harm up to 4.5 hours after onset of ischemic
stroke and there was no net benefit when administered between the 4.5 and 6 hour time after
stroke onset (Lansberg, Schrooten, Bluhmki, Thijs, & Saver, 2009). This large pooled analysis
showed the number needed to treat for benefit was 3.6 for patients treated between 0 and 90
minutes, 4.3 with tPA administration between 91 and 180 minutes, 5.9 with tPA administration
between 181 and 270 minutes, and 19.3 between 271 and 360 minutes. The estimates for number
needed to treat for harm for the corresponding time frames were 65, 38, 30, and 14 respectively
4

(Lansberg, Schrooten, Bluhmki, Thijs, & Saver, 2009). Furthermore, patients with door-toneedle time for administration of intravenous tPA of less than 60 minutes had less frequent
intracranial hemorrhage, and lower in-hospital mortality when compared to patients with greater
than 60 minutes door-to-needle time (Fonarow, Smith, Saver, Reeves, et al., 2011). In fact, every
reduction in door-to-needle time of 15 minutes was associated with a 5% decrease for in-hospital
mortality (adjusted odds ratio of 0.95: 0.92 to 0.98; P = 0.0007).

Organizational guidelines
Evidence from these trials has been transformed into recommendations from several
national, international, and accrediting organizations. The AHA/ASA guidelines has set the
target for primary stroke center of a door-to-needle time of within 60 minutes of patient’s arrival
to the emergency room with onset of stroke symptoms (Adams, del Zoppo, Alberts, Bhatt, et al.,
2007). The NINDS national symposium on the rapid identification and treatment of acute
ischemic stroke calls for a door-to-needle time of within an hour of patient’s presentation to the
emergency room (Furlan, 1997). The Joint Commission requires primary stroke care centers to
administer tPA within 60 minutes of an ischemic stroke patient’s arrival to the emergency room,
in at least 80% of the cases (Joint Commission, 2011).
Despite the evidence and recommendations, the door-to- needle time in accredited stroke
centers varies. An analysis of 25,504 ischemic stroke patients that were treated with tPA in 1082
Get With the Guidelines-Stroke (GWTS-Stroke) hospitals revealed a median door-to-needle time
of 78 minutes, with less than one third of the patients who arrive within three hours of stroke
symptom onset having a door-to-needle time of less than 60 minutes (Fonarow, Smith, Saver,
Reeves, et al., 2011). Another study evaluated data from 57 academic and community centers in
5

the United States found the median time from stroke onset to treatment was 2 hours 44 minutes
with an average door-to-needle time of 96 minutes (Albers, Bates, Clark, Bell, Verro, &
Hamilton, 2000). Hence, the need remains to identify hindrances in the stroke care processes of
primary stroke centers that delay timely administration to tPA to achieve the maximum
neurological improvement in the stroke patients.

Purpose of the Study
The purpose of this study is to identify the areas in the stroke alert care process within a
community based primary stroke center, that delay the administration of tPA within 60 minutes
of an eligible ischemic stroke patient’s arrival to the emergency room.

Research Questions
What are the in-hospital factors that increase time to administration of tissue plasminogen
activator in stroke patients who seek medical attention within the critical four hour window and
who qualify for the treatment?
Do patients who have times to administration of tPA greater than 60 minutes differ
significantly from patients who have times equal to or less than 60 minutes?

6

CHAPTER 2: REVIEW OF LITERATURE
Stroke Development
Stroke occurs as a result of interruption to the cerebral blood flow, causing extensive
changes in cellular homeostasis. Approximately 70 % of the strokes are ischemic in nature, and
15% are hemorrhagic. The absence of extravasated blood in the brain parenchyma is what
differentiates ischemic stroke from hemorrhagic stroke (Zivin, 2011). Though some blood flow
to the ischemic brain is maintained by collateral circulation, the critical supply of oxygen and
glucose necessary for normal brain function is impaired during a stroke (Crocco, Tadross, &
Kothari, 2009). The average rate of cerebral blood flow is 40 to 60 ml/100g of brain per minute.
When this level drops to 15 to 18ml/100g of brain, the brain begins to lose its electrical activity.
Further drops in cerebral blood flow results in brain cell death. The most common disorder that
leads to a stroke is atherosclerosis. Often, a thrombus can form on the atherosclerotic plaque,
which eventually breaks off and flows into the blood stream, leading to obstruction of blood flow
(Zivin, 2011).
The clinical manifestations of stroke depend on the artery or blood vessel that is occluded
and are as follows (Crocco, Tadross, & Kothari, 2009):


Middle cerebral artery occlusion causes symptoms such as contralateral
hemiparesis, sensory loss mainly of arm and face, contralateral inferior
quadrantanopsia, expressive aphasia or anosognosia and spatial disorientation.



Anterior cerebral artery occlusion causes contralateral hemiparesis, and sensory
loss that is worse in leg.
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Posterior cerebral artery occlusion causes memory impairment, contralateral
homonymous hemianopia or superior quadrantanopia.



Superior cerebral artery occlusion causes gait disturbance, gaze paresis,
contralateral hemiparesis, somnolence, nausea, dizziness, headache progressing to
ipsilateral hemiataxia, dysarthria.



Basilar artery occlusion causes sensory loss, contralateral hemiparesis, or
cerebellar signs.



Basilar apex occlusion causes amnesia and bilateral blindness



Internal carotid artery occlusion causes symptoms associated with middle cerebral
artery and ipsilateral blindness.

The survival of neurons in an ischemic stroke is influenced by the duration of occlusion;
with prolonged occlusion causing an increase in cerebral infarction as well as irreversibility of
neurological deficits (Crocco, Tadross, & Kothari, 2009). Hence the critical need to recanalize
the occluded artery and reperfuse the ischemic areas of brain with thrombolytics such as tissue
plasminogen activator (tPA) within the narrow treatment window is of paramount importance.

Evaluation and Diagnosis of Acute Ischemic Stroke
Regardless of the severity of stroke symptoms, patients who present with stroke type
symptoms should be treated with the same urgency as a patient who presents with acute
myocardial infarction or a severe trauma (Adams, del Zoppo, Alberts, Bhatt, Brass, et al., 2007).
Hospitals should have efficient pathways and processes in place to evaluate potential stroke
patients. There should be simultaneous notification of stroke team and implementation of stroke
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care pathways while evaluation of the potential stroke patient is going on in the emergency
department. Initial evaluation during the initial diagnosis of acute ischemic stroke includes:
History and physical examination: The single most important piece of history is the
timing of symptom onset as this determines the eligibility for thrombolytic treatment. For
patients who cannot speak or wakes up with stroke symptoms, the time of onset reverts back to
the time when they were last seen in a normal condition (Adams, del Zoppo, Alberts, Bhatt,
Brass, et al., 2007). It is also important to ask other questions that pertain to the eligibility of tPA
such as current use of anticoagulants. Conditions or symptoms that mimic stroke should be
considered such as conversion disorder, hypoglycemia, seizures, complicated migraines and
hypertensive encephalopathies. A complete and thorough physical examination should continue
through from the initial assessment of airway, breathing and circulation.
Neurological examination and stroke scale scores: The emergency department
physician’s neurological assessment should be brief and thorough. This usually precedes the
examination by the neurologist on call. The use of standardized stroke scales such as national
institute of health stroke scale (NIHSS) or the modified Rankin scale further enhances the
examination. The modified Rankin scale (Table 1) is a simplified overall assessment of function
that extends from no disability (score of 0) to severe disability (score of 5). The NIHSS (Table 2)
is a 42 point scale that has 11 categories of neurological deficits. These scales help to identify the
possible location of vessel occlusion, quantify the degree of neurologic deficit and identify
patient’s eligibility for various interventions (Adams, del Zoppo, Alberts, Bhatt, Brass, et al.,
2007).
9

Table 1: Modified Rankin Scale
Score

Description

0

No symptoms at all

1

No significant disability despite symptoms; able to carry out usual activities and duties

2
3

Slight disability; unable to carry out all previous activity, but able to manage affairs without
assistance
Moderate disability, requiring some help, but able to walk without assistance

4

Moderately severe disability; unable to walk or attend to physical needs without assistance

5

Severe disability; bedridden, incontinent and requiring constant nursing care and attention

6

Death

Note. Adapted from “Interobserver agreement for the assessment of handicap in stroke patients”, by J.C. Van
Swieten, P. J. Koudstaa, M. C. Visser, et al., 1988, Stroke, 19, p.604
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Table 2: National Institute of Health Stroke Scale
Item
1a. Level of consciousness

1b. Questions
Ask patient’s age and month. Must be exact
1c. Commands
Ask patient to open/close eyes, grip and release nonparetic hand.
2. Best gaze
Horizontal extra ocular movements by voluntary or
reflexive (oculocephalic maneuver) testing.
3. Visual fields
Test by confrontation or threat as appropriate. If
monocular, score field of good eye.
4. Facial palsy
If stuporous, check symmetry of grimace to pain.
Paralysis (lower face).

5a. Left motor arm
5b. Right motor arm
Arms outstretched 90° (if patient is sitting or 45° (if
supine) for 10 seconds. Encourage best effort, note
paretic side.
6a. Left motor leg
6b. Right motor leg
Raise leg to 30° (always test patient supine) for 5
seconds.
7. Limb ataxia
Check finger-nose-finger; heel-shin; score only if out of
proportion to weakness.

Score
0 = Alert and responsive
1 = Arousable to minor stimulation
2 = Arousable only to painful stimulation
3 = Unarousable or reflex responses
0 = Both correct
1 = One correct
2 = Neither correct
0 = Both correct
1 = One correct
2 = Neither correct
0 = Normal
1 = Partial gaze palsy; abnormal gaze in one or both eye
2 = Forced eye deviation or total paresis which cannot
be overcome by oculocephalic maneuver
0 = Normal
1 = Partial hemianopia, quadrantanopia, extinction
2 = Complete hemianopia
3 = Bilateral hemianopia or blindness
0 = Normal
1 = Minor paralysis (normal looking face, asymmetric
smile)
2 = Partial paralysis
3 = Complete paralysis (upper and lower face)
0 = No drift
1 = Drift but does not hit bed
2 = Some antigravity effort, but cannot sustain
3 = No antigravity effort, but minimal movement present
4 = No movement at all
X = Unable to assess due to amputation, fusion, etc.

0 = No ataxia (or aphasic, hemiplegic)
1 = Ataxia present in one limb
2 = Ataxia present in two limbs
X = Unable to assess as above
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Item
8. Sensory
Use safety pin. Check grimace or withdrawal if
stuporous. Score only stroke related losses.

9. Best language
Ask patient to describe cookie jar picture, name objects,
read sentences. May use repeating, writing, stereognosis.
10. Dysarthria
Ask patient to read or repeat a list of words.

11. Extinction and inattention
Simultaneously touch patient on both hands, show
fingers in both visual fields, ask patient to describe
deficit, left hand.

Score
0 = Normal
1 = Mild to moderate unilateral sensory loss but patient
aware of touch.
2 = Serve to total sensory loss, patient unaware of touch
(or bilateral sensory loss or comatose)
0 = Normal
1 = Mild-moderate aphasia
2 = Severe aphasia(almost no information exchanged)
3 = Mute, global aphasia, or coma
0 = Normal
1 = Mild-moderate dysarthria
2 = Severe, unintelligible or mute
3 = Severe, unintelligible or mute
X = Intubation or mechanical barrier
0 = Normal, none detected (or severe visual loss with
normal cutaneous responses)
1 = Neglects or extinguishes to bilateral simultaneous
stimulation in any sensory modality
( visual, tactile, auditory, spatial, or personal inattention)
2 = Profound hemi-inattention or extinction in more than
one modality

Note. Adapted from National Institute of Health Stroke Scale (NIHSS), by National Institute of Health, Retrieved
Oct 1, 2011 from www.ninds.nih.gov/doctors/NIH_Stroke_Scale_Booklet.pdf
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Diagnostic tests: Some of the initial diagnostic tests done to aid with the diagnosis of
stroke and rule out other causes are complete blood count, blood glucose, comprehensive
metabolic profile, prothrombin time, activated partial thromboplastin time and international
normalized ratio. All patients should also have a non contrast brain CT to rule out hemorrhage.
Since cardiac abnormalities are common among stroke patients, cardiac enzymes, 12 lead
electrocardiogram and a clinical cardiovascular examination should be completed (Adams, del
Zoppo, Alberts, Bhatt, Brass, et al., 2007).
The number of diagnostic tests performed initially on the stroke patient should be limited
due to the critical time factor, with history taking and neurological examination remaining the
cornerstone of diagnostic evaluation.

Initial Management of Patients with Acute Ischemic Stroke
The need to maintain medical stability and salvage ischemic brain tissue that is not
already infarcting, remains the primary goal during the initial phase of management (OliveiraFilho & Samuels, 2011). Restoration of blood flow is achieved from the utilization of
thrombolytic therapy, which has a narrow therapeutic time frame. The US Food and Drug
Administration approved the use of intravenous recombinant tissue plasminogen activator (tPA)
in 1996, for use within 3 hours of stroke onset (Adams, del Zoppo, Alberts, Bhatt, Brass, et al.,
2007). This approval was based on the results of the clinical trials conducted by the National
Institute of Neurological Disorders and Stroke (NINDS).
The NINDS (1995) study randomly enrolled 624 patients into treatment with intravenous
tPA vs placebo, within 3 hours of stroke onset. Patients had to meet multiple strict criteria to be
enrolled in the study, which included no evidence of hemorrhage on scan, no prior stroke or
13

trauma within prior 3 months, no surgery within 14 days, no arterial puncture within 7 days, no
recent use of anticoagulants, no gastrointestinal or urinary tract bleed within 21 days, had rapidly
improving symptoms, or had seizure at the time of stroke onset. Despite an increased incidence
of symptomatic intracerebral hemorrhage in the treatment group, patients in the tPA intervention
group within 3 hours of stroke onset, had improved clinical outcome at 3 months and were 30%
more likely to have minimal or no disability at 3 months compared to the placebo group
(NINDS, 1995).
In order to further assess the safety profile and clinical outcomes associated with
intravenous tPA use, a phase 4 study known as the Standard Treatment with Alteplase to Reverse
Stroke (STARS) study, was mandated by FDA. This prospective study enrolled 389 patients
treated at 57 hospitals and followed their clinical course post tPA intervention for acute ischemic
stroke. The results demonstrated good clinical outcome at 30 days, with approximately 43% of
patients being functionally independent. Lower rates of intracerebral hemorrhage were also noted
when compared to the NINDS study (Albers, Bates, Clark, Bell, Verro, & Hamilton, 2000).

Extension of thrombolytic treatment from 3 to 4.5 hours
The European Cooperative Acute Stroke Study (ECASS III) investigators conducted their
third clinical trial to test the efficacy and safety of tPA treatment between 3 to 4.5 hours. A total
of 821 patients were randomized to the treatment and placebo group. This was a double blinded,
parallel group trial. Results demonstrated a modest but significant improvement in the clinical
outcome of patient who received tPA between 3 to 4.5 hours as evidenced by a modified Rankin
score of 1 or less (Hacke, Kaste, Bluhmki, Brozman, Dávalos, et al., 2007). The rate of
intracranial hemorrhage was higher in the treatment group than with the placebo group as noted
14

with other studies. However, mortality between the two groups did not show a significant
difference. Unlike the NINDS trial, patients with severe strokes were excluded from this trial.
This could be the possible explanation of improved outcomes in both placebo and treatment
groups of the ECASS III trial, as patients enrolled had initial milder severity of stroke symptoms.

Intravenous thrombolytic administration
Prior to administration of intravenous tPA, it is necessary to ensure that the patient is
within the recommended time window, from the initial onset of stroke symptoms. The eligibility
criteria, dosing of tPA and monitoring after and during administration of tPA are discussed
below.
Eligibility criteria: The clinical diagnosis of ischemic stroke must be made with
measurable neurologic deficit (Oliveira-Filho , & Samuels, 2011). The patient should have had a
non hemorrhagic stroke as determined by the CT scan. The CT scan should not show evidence of
a multilobar infarction with hypodensity involving greater than 33 % of cerebral hemisphere, in
order to be eligible for tPA.
Dosing: The dose of tPA is calculated at 0.9 mg/kg of actual body weight, with a
maximum dose of 90 mg. An initial bolus of 10 % of the total dose is given over one minute,
followed an infusion of the remainder dose over one hour (Oliveira-Filho, & Samuels, 2011).
Monitoring: Vital signs and neurological checks must be monitored every15 minutes for
2 hours, then every 30 minutes for six hours and then hourly for 24 hours. Invasive procedures
and use of anticoagulant or antiplatelet drugs must be avoided. During the first 24 hours blood
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pressure must be maintained below a systolic of 180 mm Hg and diastolic of 105 mm Hg
(Oliveira-Filho , & Samuels, 2011).

The ‘Golden Hour’ for Stroke Thrombolysis
The average duration of an acute ischemic infarct from onset to completion differs widely
from patient to patient. For a non lacunar stroke, the duration of evolution may extend from 8 to
12 hours (Saver, 2006). The individual differences is influenced by location of vessel occlusion,
level of ischemic preconditioning, levels of collaterals, and several other factors including blood
sugar, blood pressure and volume of blood (Kidwell, Alger, & Saver, 2003).Using modern
quantitative neurosterology, an average human brain is estimated to have approximately 130
billion neurons (Saver, 2006).
Utilizing quantitative estimates of the rate of neural circuitry loss in an acute ischemic
stroke, investigators were able to predict the rate of neuron loss. Patients experiencing a large
vessel ischemic stroke loses 1.9 million neurons, 14 billion synapses and 7.5 miles of myelinated
fiber every minute. That translates to 32,000 neurons, 230million synapses and 200 meter of
myelinated fibers every second of an acute ischemic event. The brain ends up losing as many
neurons as it would have in 3.6 years of normal aging, for every hour of a stroke where treatment
is delayed (Saver, 2006).
A pooled analysis of six major randomized clinical trials of acute stroke using
intravenous tPA was conducted to calculate time specific number needed to treat estimates over
the entire range of clinically relevant functional outcomes. Patients were divided into four main
time categories, each consisting of a 90 minute treatment time window. The time categories were
16

0 to 90 minutes, 91 to 180 minutes, 181-270 minutes and 271 to 360 minutes. The analysis
revealed a progressive increase in number needed to treat to benefit with intravenous tPA with
longer treatment time windows and a progressive decrease in number needed to treat to harm
with longer treatment time windows (Lansberg, Schrooten, Bluhmki, Thijs, & Saver, 2009).
Every 10 minute delay in starting a tPA infusion among 100 tPA eligible patients resulted one
less patient having an improved disability outcome (Lansberg, Schrooten, Bluhmki, Thijs, &
Saver, 2009).
These findings further emphasizes the need for emergent care during an acute ischemic
stroke as human nervous tissue is irretrievably lost, resulting in lifelong disability and poor
functional outcomes.

Benefits of Early Stroke Thrombolysis
In an acute ischemic stroke, the benefits of tPA administration is strongly time
dependent, with the greatest therapeutic benefit being achieved early on after symptom onset and
gradually declines with time. Early administration of tPA have been associated with lower
mortality and greater neurological improvement, as demonstrated by the studies described below.
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Table 3 : Synthesis of Articles related to Early tPA Administration

Primary
Study

Sample and Settings

Characteristics of
Interventions

Results

Benefits of Early
Administration

Limitations

Fonarow,
Smith, et
al., 2011

Retrospective review of data from
acute ischemic stroke patients
treated with tPA within 3 hours of
symptom onset in 1082 hospitals
participating in the Get With the
Guidelines–Stroke Program from
April 1, 2003, to September 30,
2009.
Total sample was 25,504 patients.

No direct intervention.

Door-to-needle times of < 60 minutes
was documents in 26.6% of sample
(6,790 of 25,504)

Inpatient case fatality rate
lower (8.6% vs. 10.4%,
p=0.0001)
Rates of intracranial
hemorrhage within 36
hours were lower (4.7%
vs. 5.6%, p=0.002)
Odds of mortality was 5%
lower with every 15minute reduction in doorto-needle time (OR= 0.95;
95% CI: 0.92 to 0.98)

Data used in
this was only
from major
large
teaching
hospitals

Goal was to determine frequency,
patient and hospital characteristics,
and temporal trends in patients
treated with
door-to-needle times > 60 minutes.

Consecutive patients admitted with
the principal clinical diagnosis of
acute stroke or TIA by prospective
clinical identification, retrospective
identification through the use of
discharge codes, or a combination.
Abstracted data included
demographics, medical history,
onset time
of stroke symptoms (recorded as
last known well time), arrival time,
in-hospital diagnostic studies,
treatments and procedures,
discharge treatments and
counseling, tPA treatment initiation
time, tPA complications, inhospital mortality, and discharge
destination.

Patient Characteristics of Door-toneedle times of < 60 minutes:
Younger (68.9 years vs. 70.1 years ,
p<0.0001)
Male (54.0% vs. 49.7%, p<0.0001)
White (77.0% vs. 75.7%, p=0.0115)
EMS transport (85.9% vs. 84.2%,
p<0.0001)
Hospital Characteristics of Door-toneedle times of < 60 minutes:
Shorter median time from arrival to CT
(18 vs. 24 mins, p<0.0001)
Time from arrival to CT < 25 mins
(68.5 vs. 53%, p<0.0001)
Higher volume of tPA administration
20+ patients (23.5 vs. 15.4, p<0.0001)
TJC Primary Stroke Center (68.5% vs.
65.9%, p<0.0001)
Arrival “on hours” (OR=1.27; 95% CI:
1.18 to 1.37)

Primary
Study

Sample and Settings

Characteristics of
Interventions

Results

Benefits of Early
Administration

Limitation

Hacke,
Donnan, et
al., 2004

Pooled analysis of common data
elements from six
randomized placebo-controlled
trials using tPA.

No direct intervention.

Median age was 68 years,
84·6% were reported as white, 9·1%
as black, 2·0% as
Hispanic.
Median baseline NIHSS score was 11,
and
median onset to treatment of 243
minutes. 1847 patients (67%) were
treated
for longer than 3 h after symptom
onset.

Improved functional
outcomes with early tPA;
for 0 to 90 minutes (OR=
2.8, 95% CI: 1.8 to 4.5),
for 91 to 180 minutes
(OR=1.6, 95% CI: 1.1 to
2.2), for 181 to 270 minutes
(OR=1.4, 95% CI: 1.1 to
1.9), and for 271 to 360
minutes (OR = 1.2, 95%
CI: 0.9 to 1.5).
Mortality rates lower in
those treated within 0-90
minutes when compared to
others (0.88, 95%: 0·54–
1·46).

Differences
in trial
methodologi
es

Total of 2775 patients treated at
more
than 300 hospitals in 18 countries.
Goal was to determine
whether time-to-treatment with
intravenous thrombolytic
therapy is a critical predictor of
therapeutic benefit.

Patients from six major trials with
similar strict inclusion and
exclusion criteria for enrollment
and administration of tPA. Similar
outcome measures were utilized
such as
NIHSS, modified
Rankin Scale, and Barthel Index up
to 3 months after
stroke onset, calculated mortality,
occurrence of hemorrhage with CT,
and clinical scales for their primary
outcome measures.
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Primary
Study

Sample and Settings

Characteristics of
Interventions

Results

Benefits of Early
Administration

Limitation
s

Marler,
Tilley, et
al., 2000)

Retrospective review of data from
two major tPA stroke trials
conducted at eight centers using
over 40 hospitals.
A total of 622 patients were
included in the study.
Goal was to analyze the
relationship of onset-to-treatment
time to outcome at 3 months, early
improvement at 24 hours, and
intracranial hemorrhage within 36
hours.

No direct intervention.
The NINDS rt-PA Stroke Study
was performed
in two parts, each of which was a
separate trial. The two
parts differed only in the
prospectively defined primary
outcome. Data from both parts of
the study were combined
for analyses to obtain more
statistical
power and a more complete picture
of the effect of onset to treatment
time on
patient outcomes.
A favorable outcome was
defined as recovery with minimal
or no deficit 3 months
after treatment using four outcome
measures: the Barthel Index ,
modified Rankin Scale, Glasgow
Outcome
Scale, and NIHSS score.

Onset of time to treatment in between
0 to 90 vs. 91 to 180 minutes, 86 vs.
153 minutes.
Delay from admission to treatment 53
vs. 84.7 mins.

Improved functional
outcome at 24 hours: for 0
to 90 minutes (OR = 1.71,
95% CI: 1.09 to 2.70) and
for 91 to 180 minutes (OR=
1.12, 95% CI: 0.71
to 1.76). An OR > 1
indicates that the odds of a
four or more point NIHSS
improvement at 24 hours in
tPA treated patients when
compared to placebo.

Baseline
NIHSS is a
good
predictor of
outcome,
however,
there was an
imbalance in
the NIHSS
severity of
stroke
randomized
in the two
treatment
groups at
different
onset to
treatment
time.
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Favorable clinical outcome
at 3 months: for 0 to 90
minutes (OR = 2.53, 95%
CI: 1.53 to 4.19), for the 91
to 180 minutes (OR = 1.61,
95% CI: 1.02 to 2.55).

Sample and Settings

Characteristics of
Interventions

Results

Benefits of Early
Administration

Single-center assessment of the
A total of 878 patients with
ischemic stroke received
thrombolysis
within 4.5 hours from the symptom
onset, between January 2003, and
December 2008.
Purpose was to identify effect of
ultra-early
thrombolysis on patient outcomes.

No direct intervention.
All patients were prospectively
included in the study, that is, all
consecutive patients considered
eligible for stroke
thrombolysis and treated within the
time window of 4.5 hours from
symptom onset .

Median age was 70.5 years, 399
(45.4%) females. Median baseline
NIHSS was 9. Median onset to
treatment time (OTT)was 115 minutes.
257 (29%) had OTT < 90 minutes and
87 (10%) had
OTT < 70 minutes.

Improved favorable
outcome for < 70minutes
OTT when compared to >
90 minutes, after adjusting
for baseline stroke severity
based on NIHSS.
Specifically, for the patients
with
NIHSS 7 to 12 (OR =5.15,
95% CI: 1.50 to 27.5) and
for those with NIHSS > 13
(OR= 2.74, 95% CI:1.26 to
5.90). Of the patients with
OTT >90 minutes, those
with NIHSS 7 to 12 had an
OR of 1.72 (1.00 to 2.96)
for a favorable outcome,
and those with NIHSS >13
had lower mortality than
the
ones with OTT > 90
minutes (16.4% versus
29.5%).

Primary
Study
Strbian,
Soinne, et
al., 2010
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Limitation
s

Prehospital Delays to Early Stroke Thrombolysis
Although the benefits of early stroke thrombolysis and timely administration of tPA have
been demonstrated, only a small amount of patients actually receive thrombolytic treatment
(Schestatsky & Picon, 2005). This has been attributed to the delays that are encountered along
the patient pathway; along with the narrow time window of 3 hours for effective thrombolytic
therapy (Dirks, Niessen, Huijsman, van Wijngaarden, et al., 2007).
A systematic review of literature was conducted to identify barriers to the administration
of tPA for acute stroke. All prospective and retrospective observational studies that addressed the
duration and nature of barriers and delays to thrombolysis from 1990 to 2001 were retrieved
(Kwan, Hand, & Sandercock, 2004). Publications that were opinions, not original research,
studies of specialized groups of stroke patients and studies that only looked at patients who
received tPA were excluded from the analysis. Of the 54 studies included in the review, majority
reported a mean delay time of 2 to 6 hours from stroke onset to arrival to the hospital. Another
systematic review was conducted on literature published between 1995 to 2009 to identify
barriers to thrombolytic therapy (Johnson, & Bakas, 2010). Based on these two reviews, the three
major prehospital factors that negatively influenced the timely arrival to hospital and the
administration of tPA were:
1. Patient or family knowledge deficit regarding stroke symptoms and acuity: This
category included factors such patients living by themselves, lack of witness when
stroke symptoms occurred, patient’s refusal to go to hospital, lack of recognition
of stroke symptoms by patient or family, and lack of urgency on the part of
patient or family to seek help once symptoms developed;

2. Non emergent mode of arrival: This delay occurred when patients did not call for
an ambulance or attempted to call their primary care provider first to discuss their
symptoms. Patients with more severe stroke symptoms, hemorrhagic stroke
patients, older patients, and patients with witnessed stroke were more likely to call
for an ambulance and hence have shorter delay in arriving at the hospital; and
3. Delay in emergency medical personnel services: This included delay in timely
arrival of ambulance, delay in ambulance arrival at the patient to reaching the
hospital or triage of stroke patients as non urgent by emergency medical personnel
(Johnson, & Bakas, 2010; Kwan, Hand, & Sandercock, 2004).

Inhospital Delays to Early Stroke Thrombolysis
Though delayed presentation to the emergency room after the onset of stroke symptoms
has been identified as the major limiting factor to utilization of tPA, several inhospital factors
have also been identified. In fact, those patients who arrived very early on after the onset of
stroke symptoms had a longer arrival to treatment time. For every 30 minute delay between onset
of stroke symptoms and arrival to the emergency room, there was an associated 15 minute
decrease in time between arrival and administration of tPA (Albers, Bates, Clark, Bell, et al.,
2000).
In an Austrian study, data was prospectively collected on all admitted stroke patients
using standardized variable definitions and scores (Ferrari, Knoflach, Kiechl, Willeit, et al.,
2010). Of the 3287 patients who received intravenous thrombolysis, 2663 patients were included
in the analysis. Patients with unknown stroke onset to arrival time and those patients with door to
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treatment time of greater than 240 minutes were excluded from the study. After multivariate
adjustments and even after controlling confounding variables such as stroke severity, weekend
admissions, age, gender , transportation to and within the hospitals, and imaging modality, the
findings were significant. Patients who arrived within 60 minutes had a longer door to treatment
time when compared to patients who arrived between 61 to 120 minutes and 121 to 180 minutes
after stroke onset, whose door to treatment time were 6.9 minutes and 13.9 minutes shorter,
respectively (p < 0.001).
A similar retrospective chart analysis was conducted on a smaller scale at an US
academic medical center involving 31 patients. An inverse relationship between early arrival to
hospital and tPA administration time was discovered (Romano, Muller, Merino, et al., 2007).
Investigators of both the above mentioned studies make the assumption that this delay may be
related to the decreased sense of perceived urgency when patients arrive early on after stroke
onset. The feeling of ‘having more time’ may produce small delays in different levels of patient
care and management.
Systematic review of literature further identified inhospital factors that act as barriers to
timely administration of tPA (Johnson, & Bakas, 2010; Kwan, Hand, & Sandercock, 2004).
Specific factors causing inhospital delay to the delivery of thrombolysis identified in these
reviews included:


Delay in medical assessment: This may be related to incorrect triaging of a stroke
emergency and thereby delay in alerting the acute stroke team, delay in initial
medical assessment, and delay in neurologist’s assessment.
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Delay in neuroimaging: This delay occurred due to late order entry for scan, delay
in transporting the patient to radiology department, delay in scanning in patient
and reporting of the results by the radiologist. Major organizational changes such
as relocating computerized tomography (CT) scanner to the emergency room,
prenotification by emergency medical personnel and development of a stroke
team was able to reduce delays related to CT by 1 hour and reduce door to
treatment time by 38 minutes (Lindsberg, Häppölä, Kallela, Valanne, Kuisma, &
Kaste, 2006).



Delay in obtaining consent for thrombolysis: This delay occurs from difficulty in
obtaining consent from patients due to their decreased level of consciousness or
speech impairment associated with acute ischemic stroke. The lack of a
standardized protocol for capacity assessment in acute ischemic stroke further
adds to this delay (White-Bateman, Schumacher, Sacco, & Appelbaum, 2007).



Delay from physician uncertainty regarding treatment with tPA: This delay arises
from physician uncertainty regarding diagnosis of acute stroke, difficulty in
initiating treatment within 3 hours and reluctancy in starting tPA due to lack of
confidence in tPA treatment or trial results.



Delay from inefficient process of emergency stroke care. This delay has been
attributed from delays in assessment, transfers and lack of collaboration. The lack
of an expedited stroke triage pathway involving close collaboration between
emergency personnel, emergency physicians, nurses, neurologist, and radiologist,
can further contribute to inhospital delay (Lau, Soo, Graham, Woo, et al., 2010).
25



Delay from other barriers: These include delay in transfer of a patient from a non
stroke center, delay in obtaining or retrieving prior records, delay in obtaining
drug from the pharmacy, delay in performing phlebotomy, inadequate training of
emergency room physicians, and low level of accuracy of stroke diagnosis by
emergency medical personnel.

Summary
This chapter discusses the benefits and need for emergent care and treatment of an acute
ischemic stroke patient. Research related to the timely administration of thrombolytic treatment
is discussed, along with the prehospital and inhospital delays that are commonly encountered.
These findings have influenced major organizations such as the The Joint Commission, the
American Heart Association and American Stroke Association (AHA/ASA), and the National
Institute of Neurological Disorders and Stroke (NINDS), to recommend that the door to needle
time of a patient experiencing ischemic stroke remain within 60 minutes. However, inhospital
delays that occur during this initial golden hour for thrombolytic treatment need to be analyzed
further to improve stroke care processes in the emergency department.
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CHAPTER 3: METHODS
Setting
The study took place in a community healthcare organization in Central Florida. The
organization is a primary stroke care center, certified by the Florida Agency for Health Care
Administration (AHCA). A primary stroke center is a healthcare facility where medical
professionals work to together to provide rapid evaluation, treatment, and early rehabilitation of
acute stroke patients. The AHCA criteria for stroke center certification is similar to the criteria
established by the Joint Commission and is outlined in Appendix A.

Sample Criteria and Method of Data Collection
A purposive sample of all patients admitted with the diagnosis of ischemic stroke and
received antithrombolytic treatment such as intravenous tPA, in the emergency room was
included in the study. Patients who developed ischemic stroke and received thrombolytics during
the course of their hospitalization were excluded from the study. Records with missing
information about primary time factors, as discussed in the procedure section were excluded
from the study.
The data were extracted from the patient’s electronic health record and the stroke alert
process time log, which is maintained on each individual patient diagnosed with ischemic stroke
in the emergency room. The organization utilizes the Eclipsys® electronic health record centered
on the Sunrise Clinical Manager™. The sampling period extended from January 2009 to
February 2012. This time period was chosen as the stroke alert process time log was available
only for this period. Data from 2008 when the healthcare facility initially became certified as a
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Primary Stroke Center were unavailable and hence not included in the study. Due to the low
incidence of tPA administration, data from 40 patients were obtained from this time frame.

Protection of Human Subjects
Approval was obtained from the Institutional Review Boards (IRBs) of both the local
community hospital organization as well as from the University of Central Florida, prior to
beginning data collection. Any amendment to the protocol was requested and approved by both
of these IRB’s prior to data collection. Risk of disclosure of patient identity was minimal.

Study Design
A retrospective descriptive design was utilized to identify areas of delay in the stroke
alert process that hinder the administration of tPA within 60 minutes of patient arrival to the
emergency room. This design was chosen to allow a retrospective chart review to identify areas
where process improvement can be made in the treatment of ischemic stroke patients. The steps
involved in the stroke alert process are outlined in Figure 1. Some of the threats to internal
validity of the proposed design include incomplete documentation, problems in verification of
documented information and variance in time documentation by medical professional. These
threats were resolved and addressed utilizing the plan outlined in Table 5. These threats were
found to be minimal as trained members of the stroke alert team maintained the running time log
during the care of a patient who presented to the emergency room with ischemic stroke type
symptoms.
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Table 4: Sample Stroke Alert Time Log
Time

Event

…….

Time of arrival or time identified with stroke symptoms

…....

Time patient last seen normal

…….

Time stroke alert was called

…….

Time patient was first evaluated by a physician

…….

Time specimen was sent to lab

…….

Time order entered for CT scan

…….

Time CT done

…….

Time CT results called to MD

…….

Time labs results become available

…….

Time neurologist consulted via Teleneuro System

…….

Time call returned by teleneurologist and patient is evaluated

…….

Time tissue plasminogen activator initiated

Note. CT = computerized tomography; MD = doctor of medicine.
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Patient walk-in

Patient arrives by EMS

ED staff triages pt, see S/S of stroke

EMS calls stroke alert prior to arrival

Stroke alert called

Pt goes directly to room

Pt triaged & evaluated by ED MD

Pt goes to CT scan

CT read within 20minutes post completion and results called to ED MD

ED MD determines need for telemedicine using exclusion criteria/CT results

MD calls Teleneuro, gets teleneuro consent. RN calls pharmacy with pt weight

Teleneuro MD collaborates with primary RN to assess pt/determines plan of care

Teleneuro MD gives orders for tPA, Primary RN obtains consent

RN facilitates delivery of tPA to ED (notifies ED pharmacist, sets up tPA, pharm tech delivers tPA to ED)

tPA administered after double verification
Figure X. The figure outlines the steps generally followed in the community hospital when a patient presents with a
stroke. tPA = tissue plasminogen activator, MD = doctor of medicine, RN = registered nurse, ED = emergency department, CT =
computerized tomography, EMS = emergency medical service, S/S = signs and symptoms.

Figure 1: Ischemic Stroke Alert Process
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Procedures
A computerized database review was executed for all patients who received tPA in the
emergency room during a three year period from January, 2009 to February, 2012. The sample
size obtained was 40 patients. Based on record review, patients were divided into two main
categories, those with door to needle time of less than 60 minutes and those with door to needle
time of greater than 60 minutes. Patient characteristics such as age, gender, ethnicity, mode of
arrival, presence of family, type of insurance and National Institute of Health Stroke Scale
(NIHSS) score was extracted for both sets of patients. Further extensive event time analysis was
done on these patients. The time factors documented in the stroke alert time process log (Table
5) were retrieved from a separate database kept in the emergency room. The lack of availability
of door to time the consent was signed was considered a drawback as anecdotal information
suggests that time needed to allow patient families to decide on treatment choices increases the
time before medication can be given.
The initial data file included the patient medical record number and was kept on a
password-protected computer. Prior to removal of medical record number, the data were coded
and each patient was assigned a unique number identifier. The medical record number and the
associated unique number identifiers were kept locked in a separate cabinet at the organization to
maintain patient confidentiality, and was accessible only by the primary investigator. The initial
data file was destroyed after coding. Each patient received the same unique number identifier for
their associated stroke alert process time log data file. A random subset of 5 charts using the
medical record number was retrieved for verification of the integrity of the data in the electronic
database.
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Table 5: Threats to Validity
Threats
Incomplete Documentation

Resolution Plan
Missing documentation in demographic characteristics was obtained
by reviewing patient records such as face sheet, history and physical
notes or consultation notes. Missing documentation in time log was
retrieved by reviewing the Sunrise Clinical System. For example, if
time data is missing as to when the lab results were called; this may
be obtained from the computer clinical system. The real time
documented as to when the lab results were entered by the laboratory
personnel will be utilized in this instance. Another example would be
missing time as to when thrombolytic administration was initiated.
This time was retrieved from the time documented in the Medication
Administration Record available in the Sunrise Clinical System.

Variance in time documentation

This wasconsidered to be minimal as members of the stroke alert
team has been trained to follow one time device in maintaining the
time log such as the clock in the room, or the time available on the
computer on wheels available in patient room.

Problems in verification of data collected

Five charts were randomly pulled and were reviewed for verification
of data collected and time documented.
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Statistical Analysis
Statistical analysis was conducted using PASW® Statistics GradPack for MAC®
database (version 20.0, SPSS, Chicago, IL, USA). Statistical significance was set at p< 0.05. The
research questions and the associated statistical analysis utilized outlined below:
1. Do patients who have times to administration of TPA greater than 60 minutes differ
significantly from patients who have times equal to or less than 60 minutes?
Descriptive statistics including mean, median, and percentages, were used to summarize
patient characteristics. In addition, patient demographic characteristics and clinical
characteristics were compared between patients with door to needle time of less than 60 minutes
and those with needle time greater than 60 minutes. Percentages were reported for categorical
variables and mean plus standard deviation will be reported for continuous variables. In order to
examine and identify differences between the two groups with regard to patient characteristics, tTest was used for continuous variables and Chi Square analysis or Fisher's Exact test was used
for nominal variables.
2. What are the in-hospital factors that increase time to administration of tPA in stroke
patients who patients who seek medical attention within the critical four hour window
and qualify for thrombolytic treatment?
The time variables for analyses were calculated from the stroke alert process time log and
included:


Onset of symptoms to door time.



Door to time stroke alert called.



Door to first evaluation by physician.
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Door to time CT results reported.



Door to time lab results become available.



Door to evaluation by teleneurologist.



Door to tPA administration time.

Descriptive statistics such as mean, median and standard deviation were used to
summarize the time intervals and identify areas in the stroke alert care process with increased
time from door to activity leading to tPA administration. Mann-Whitney U or the Student's t-test
was used to identify if any differences existed in the time intervals for the two groups.
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CHAPTER 4: RESULTS
During the 3 year study period, a total of 40 acute ischemic stroke patients who presented
to the ER and were treated with intravenous tPA were obtained. The target door to tPA time of
less than 60 minutes was achieved in only one patient ( 2.5%). However, two patients received
tPA within 62 minutes of arrival to the ER. Since a variety of clocks were used to determine
times documented in the stroke alert log, these patients were included with the group that met the
door-to-drug time goal. The small sample size of the group meeting the time goal made statistical
analysis difficult. Door to tPA time exceeded 60 minutes in the remaining 37 (92.5%) patients as
shown in Figure 2. Seven patients (17.5%) was 60 minutes outside the recommended time goal
of 60 minutes. Approximately 70 % of the patients who received tPA, were 20 minutes out of the
recommended time frame (Figure 3), thereby raising concerns of a systems problem in the care
of an acute ischemic stroke patient presenting to the ER.
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Figure 2: Number of Patients and Time Interval to tPA Administration
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Door to time TPA given (minutes)
18%

7%

7%

<60

5%

15%

60 -69
70 - 79

8%

80 - 89
90 - 99
17%

23%

100 -109
110 - 119
>120

Figure 3: Percentages of Door to Time tPA given for the Entire Group of Patients

37

Demographic characteristics for the total sample as well as those meeting or exceeding
the 60 minute goal are shown in Table 6. Both groups were similar in terms of age and gender. In
the group which received tPA within 60 minutes, 33% are male and 67% are female. In the
group who exceeded 60 minutes, 41% are male and 59% are female. The mean age of the group
which met the time goal and those that did not meet were similar, 64.33 ± 13.50 and 64.92 ±
16.55 respectively.
Half the patients were Caucasian, while the remaining patients were evenly divided
between Hispanics (25%) and African Americans (25%). Of those who received tPA within the
60 minute target, two were Caucasian and one was Hispanic. All 3 patients who received tPA
within the goal time were insured while 16 % in the other group were uninsured. Families for all
3 patients who received tPA within the target time arrived with the patient, but they were also
present in 92.5% of cases where door to drug targets were not met. Overall, there were no
significant differences between the groups.
Most patients (n=32, 80%) arrived at the ER by ambulance. The mean time from onset of
symptoms to arrival at the ER was just over 1 hour (68.03 ± 40.04 mins) for the entire group of
patients. Although the group meeting the door to drug goal took longer to get to the ER (94 vs.
66 mins), the difference was not significant. Nearly half of all patients (42.5%) were classified
as having a mild stroke while only 15% were diagnosed with a severe stroke. The median NIHSS
score for the entire group was 11.50 (IQR: 4.25 to 17.75). When time interval to tPA
administration was clustered against NIHSS score severity, no discernible pattern emerged for
early tPA administration (Figure 4).
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Table 6: Comparison of Characteristics of Ischemic Stroke Patients with Door to tPA time
of Greater than 60 Minutes and those Less than 60 Minutes
Total Sample
(n = 40)
M (SD)
Median

≤ 60 minutes
(n=3)
M (SD)
Median

Age

64.88 (16.20)
66.50

64.33 (13.50)
64

64.92 (16.55)
67

Onset of Symptoms
to Door

68.03 (40.04)
48.50

93.67 (40.54)
96

65.95 (39.46)
48

N (%)

N (%)

N (%)

Gender
Male
Female

16 (40%)
24 (60%)

1 (6.2%)
2 (8.3%)

15 (93.8%)
22 (91.7%)

1.00

Ethnicity
Caucasian
African American
Hispanic

20 (50%)
10 (25%)
10 (25%)

2 (10%)
0 (0%)
1 (10%)

18 (90%)
10 (100%)
9 (90%)

0.582

Mode of Arrival
EMS
Walk in

32 (80%)
8 (20%)

1 (3.1%)
2 (25%)

31 (96.9%)
6 (75%)

.096

Presence of Family
Yes
No

37 (92.5%)
3 (7.5%)

3(100%)
0

34 (91.9%)
3 (100%)

1.00

Type of Insurance
Medicare
Private
Uninsured

17 (42.5%)
17 (42.5%)
6 (15%)

1 (5.9%)
2 (11.8%)
0

16 (15%)
15 (88.2%)
6 (100%)

0.61

Median (IQR)
N (%)

N (%)

N (%)

Characteristic

≥ 60 minutes
(n=37)
M(SD)
Median

Stroke Severity
(NIHSS Score)
11.50 (4.25, 17.75)
Mild
17 (42.5%)
1 (33.3%)
16 (43.2%)
Moderate
8 (20%)
0 (0%)
8 (21.6%)
Moderately Severe
9 (22.5%)
1 (33.3%)
8 (21.6%)
Severe
6 (15%)
1 (33.3%)
5 (13.5%)
Note: EMS = emergency medical personnel, NIHSS = National Institute of Health Stroke Scale
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p

0.953

0.254

0.657

Figure 4: Comparison of Time to tPA Administration against severity of NIHSS score
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Time intervals associated with the acute stroke alert care process are shown in Table 7.
Overall, mean door to tPA time of 96 minutes was 36 minutes longer than the recommended
door to tPA target time. There may be a lack of urgency when patients presents early on from the
initial onset of their stroke symptoms. Patients who presented within 30 minutes of onset of
stroke symptoms had a door to tPA time of greater than 100 minutes (Figure 5). However, no
discernible pattern was observed when clustering onset of symptoms to door and time to tPA
administration.
There were no significant differences for any time intervals between door to tPA groups.
The standards for time intervals set by the AHA/ASA and the Joint Commission is 45 minutes
for lab results from the time it was ordered and 45 minutes for the time CT was obtained and
interpreted. This was achieved in 87.5% of the patients ,both for lab results as well as for CT
results. The standard time goal for physician evaluation of an ischemic stroke patient's arrival is
10 minutes and this was achieved in 80% of the patients. The mean time interval associated with
door to teleneurologist evaluation was close to an hour (52.65 ± 19.86 mins) with a median of 39
minutes. However, no standard time frame has been set for this time interval.
During this retrospective chart review some of the identifiable delays included patients
with patients with difficult intravenous accesses, patients with unstable hemodynamic,
respiratory failure requiring intubation, and patients with unusual history or presentation.
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Table 7: Time Intervals Associated with the Acute Stroke Alert Care Process
Total
(n=40)

≤ 60 minutes
(n=3)

≥ 60 minutes
(n=37)

M (SD)
Median

M (SD)
Median

M (SD)
Median

Differences in Mean
(95% CI)

P

Door to Stroke Alert Called

9.80 (13.38)
4.00

3.33 (0.58)
3.00

10.32 (13.80)
4.00

-6.99 (-23.30 to
9.32)

0.63

Door to MD Evaluation

7.75 (8.86)
5.00

8.00 (1.73)
9.00

7.73 (9.21)
4.00

0.27 (-10.63 to
11.20)

0.21

Door to CT Results

29.93 (12.69)
25.50

19.67 (3.06)
19.00

30.76 (12.83)
27.00

-11.10 (-26.29 to
4.11)

0.08

Door to Lab Results

24.08 (22.06)
19.00

30.0 (1)
30.00

24.38 (22.5)
19.00

5.62 (-21.47 to
32.71)

0.43

Door to Teleneurologist
Evaluation

52.65 (19.86)
50.00

35.33 (6.35)
39.00

54.05 (19.95)
51.00

-18.72 (-42.39 to
4.95)

0.72

Door to Time TPA given

96.13 (28.06)
90.00

59.67 (4.04)
62.00

99.1 (27.10)
93.00

-39.41 (-71.44 to 7.39)

0.00

Interval
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Figure 5: Comparison of Onset of Symptoms to Door and Door to tPA Administration
Time Interval
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CHAPTER 5: DISCUSSIONS
Despite various organizational recommendations, guidelines and multiple studies
showing the benefits of early reperfusion therapy in acute ischemic stroke patients, meeting the
goal of administration of tPA within 60 minutes of patients arrival to the ER remains elusive.
This study revealed that only 7.5% of the patients who presented to the ER received tPA within
the recommended time frame of 60 minutes. Though this number is alarming, it remains
consistent with other nationwide studies reporting low % of compliance with door to tPA times
and calls for an aggressive quality improvement initiative in the care of an acute ischemic stroke
patient. In approximately 25, 000 patients that presented to US hospitals participating in Get
With the Guidelines-Stroke (GWTG-Stroke), only one third received tPA within the
recommended 60 minutes of arrival to the ER. The median door to tPA time in this entire group
was found to be 78 minutes (Fonarow, Smith, Saver, et al., 2011). Another national study
involving 57 academic and community centers reported a median door to tPA time of 96 minutes
accounting for less than one third of the total patients who received tPA in their study period
(Albers, Bates, Clark et al., 2000). However, an international study conducted in a community
hospital reported a mean door to tPA time of 38 minutes, after the implementation of major
organizational and structural changes in the ER (Tveiten, Mygland, Ljøstad, & Thomassen,
2009).
Another interesting observation from this study was that patients with shorter onset of
symptoms to door had longer door to tPA time. The median onset of stroke symptoms to door
time between the group that received timely tPA and those that received delayed tPA was 96 and
48 minutes respectively. This finding of delayed treatment is consistent with other studies where
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"having more time" translated into "taking more time" for tPA administration (Fonarow, Smith,
Saver, et al., 2011, Ferrari, Knoflach, Kiechl, et al., 2010). The door to tPA time was found to be
much higher in patients that arrived within 60 minutes from onset of their stroke symptoms when
compared to patients who arrived 61 to 120 minutes and 121 to 180 minutes (Ferrari, Knoflach,
Kiechl, et al., 2010). This may be attributed to the lower sense of perceived urgency and the
feeling of still having enough time to administer tPA within the 4 hour window, thereby causing
varying degrees of small delays in the different steps involved in the stroke alert care process.
Time from door to stroke alert called: This is a critical element of the multidisciplinary
stroke care process, as timely recognition of stroke by following acute triage protocols reduces
time to tPA and enhances stroke care. When a patient is suspected to have stroke type symptoms
in the ER, the triage nurse alerts the ER physician. If the ER physician concurs with the
assessment, the request for a stroke alert is made. The ER contacts the main hospital operator
who then sends out a central page, alerting the stroke team. If the patient is arriving by EMS and
the ER is notified that it is a stroke code, then a central page is also sent out including the
estimated time of arrival. Once the stroke alert is called, the multidisciplinary team convenes at
the patient bedside. The median door to time stroke alert was called was 4 minutes. Proper
prioritization should be given to the stroke patient in the context of the overall activity of the
busy emergency room. Strokes should be considered a time-sensitive condition and rapid
diagnosis and treatment are essential. Activating the stroke team is the first step in achieving this
goal. (Gomez, Malkoff, Sauer, et al., 1994).
Time from door to MD evaluation: In this study, the median door to MD evaluation time
was 5 minutes for the entire group of 40 patients. The mean was also below the 10 minute target.
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This was within the target time of 10 minutes for door to MD evaluation as recommended by the
National Institute of Neurological Disorders and Stroke (NINDS) and the Joint Commission
(JC). This phase of the process will not be a target for quality improvement.
Time from door to CT results: The JC recommends that a CT scan be ordered within 25
minutes of patients arrival to the ER, with results interpreted within 45 minutes. Though the
exact time of CT order entry was not analyzed for this study, the mean door to interpreted CT
results was 19.67 ± 3.06 minutes for the group who received tPA within 60 minutes and 30.76 ±
12.83minutes for those who received tPA after 60 minutes. This target was easily achievable due
to the presence of the CT scanner within the department that is primarily used for the ER patients
only. However, there is room in this time interval for improvement, with close proximity and
accessibility to a CT scanner. The rebuilding of an ER with a CT scanner as well as with
prenotification by EMS enabled one hospital to drop its CT delay time from 63 ± 14minutes to 7
± 2 minutes (Lindsberg, Häppölä, Kallela, et al., 2006). They were further able to reduce their
door to tPA time from 88 ± 7 minutes to 50 ± 3 minutes (p < 0.0001).
Time from door to lab results: This time interval was again within the target goal set by
the national agencies where lab results are to be completed and reported within 45 minutes. The
mean time interval for door to lab results was 24.08 ± 22.06 for the entire group.
Time from door to teleneurologist evaluation: The mean time interval associated with
door to teleneurologist evaluation was 52.65 ± 19.86 minutes with a median of 51 minutes for
those who received tPA after 60 minutes of their arrival to ER. Though no specific time goal has
been set by national organization for door to evaluation by teleneurologist, the study did show
that this time interval warrants improvement by addressing potential sources of delay. More
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specific documentation of time such as the time teleneurologist was called, time of call back,
time of initial evaluation, time orders for tPA administration were given would enable closer
tracking of the process.. Additional documentation of potential delays such as delay in set up,
lack of remote technical connectivity, and language barriers needs to be noted. Previous studies
have demonstrated a delay in neurologic consultation, but were not specific to teleneurologist
evaluation. A median delay of 180 minutes (Morris, Rosamond, Madden et al., 2000) and 21.28
minutes (Keskin, Kalemoglu & Ulusoy, 2005) was found for obtaining neurospecialist
consultation. A recent retrospective study compared face to face evaluation (n=52) with
teleneurologist evaluation (n=45) in the delivery of tPA in a single hospital (Chowdhury, Birns,
Rudd, & Bhalla, 2012). The time intervals associated with door to CT, CT to drug and door to
drug were significantly better in the face to face evaluation group. Additional time may have
been utilized in obtaining consent for telemedicine evaluation and completion of telemedicine
consultation and assessment as well as related to technology failures (Chowdhury, Birns, Rudd,
& Bhalla, 2012).

Recommendations
Multiple studies have shown the efficacy and long term benefits of early thrombolytic
administration in acute ischemic stroke patients. However, in spite of guidelines and
recommendations made by various national and international agencies, obstacles remain in the
translation of research into effective clinical practice. Analysis from this study yielded results
consistent with previous studies in regards to the alarmingly low rate of administration of tPA
within 60 minutes of an eligible stroke patient's arrival to the ER. The delivery of tPA with a
short door to needle time calls for complex clinical process that requires coordination between
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departments and disciplines for timely triage, diagnosis, decision making and treatment of an
acute ischemic stroke patient. A multidimensional, highly coordinated focused effort is necessary
to bring about successful organizational change in this complex process (Schwamm, Pancioli,
Acker, Goldstein, et al., 2005).

Organizational Strategies
Lessons pertaining to organizational structure can be learned and applied from hospitals
that succeeded in reducing their door to balloon time in the care of their patients presenting with
acute ST-elevation myocardial infarction. Door to balloon time can be similar to door to tPA
time in that, both involves a complex clinical process requiring interdepartmental and
interdisciplinary coordination. The key organizational culture and structural strategies of these
successful hospitals was analyzed in a qualitative study that included 11 hospitals (Bradley,
Curry, Webster, Mattera, et al., 2005). These strategies applied to stroke care are as follows:


The presence of a shared organizational explicit goal of reducing the door to drug
time to less than 60 minutes.



The presence of visible senior management that show an interest in door to drug
time as it is an indicator of overall hospital performance.



The presence of uncompromising clinical leaders such as nurses, advanced
practice nurses and physicians who are committed in their efforts to achieve the
goal of improving door to drug time.



The presence of organizational culture that fosters persistence despite challenges
and setbacks and avoids finger pointing, taking a non blaming approach.

48



The presence of continual data feedback to monitor progress and identify
problems and successes.



The establishment of a collaborative interdisciplinary team.



The availability and development of standardized stroke care protocols and
flexibility in implementing these protocols based on rapid cycle feedbacks.
Unsuccessful strategies are dropped in the process, and successful strategies
implemented.

Practice Strategies
A national quality improvement initiative, Target:Stroke, was developed by the American
Heart Association/American Stroke Association (AHA/ASA) with the goal to improve stroke
care by focusing on reducing door to thrombolytics time in acute ischemic stroke patients and to
increase the number of eligible stroke patients that receive thrombolytics within 60 minutes of
arrival to the hospital (Fonarow, Smith, Saver, Reeves, et al., 2011b). Based on the key best
practice strategies recommended by the Target:Stroke initiative, the following areas will have to
be revisited and re-evaluated to shorten the door to tPA time:


Advance hospital notification by EMS: Advance notification can prepare ER
personnel for the arrival of the patients and ensure that the CT Scanner, when
appropriate, will be freed up for the arrival and use of the stroke patient.



Single call activation system: This system is already in effect at the community
hospital where a single call from the ER to the central page operator activates the
"Stroke Code" and notifies the stroke team of the patient's arrival.
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Rapid triage protocol and stroke team notification: Timely recognition of stroke
by utilization of acute triage protocol being in place.



Stroke tools: Once a stroke alert is called, a pre-prepared stroke packet is used
consisting of NIHSS scale, guidelines, stroke specific order sets, clinical decision
support, hospital specific algorithms of stroke pathway, and stroke alert time log
is accessed for each patient.



Rapid acquisition and interpretation of brain imaging: The availability of CT
scanner within the ER in this community hospital and the immediate notification
of the radiologist should not cause any delay in this step of the stroke care
process.



Rapid laboratory testing: The availability of the pneumatic tube system for blood
transport to the lab and the availability of a laboratory technician on the stroke
team has ensured that the target goal of lab results being available within
45minutes .



Mix tPA medication ahead of time: The AHA/ASA best practice strategy calls for
mixing the drug, setting up the bolus dose and one hour on the infusion pump,
once a patient is recognized as a potential tPA candidate. This would shorten the
time to treatment once a decision has been made and consent is signed. However,
the hospital pharmacy needs to ensure that no financial risk is involved and
further look into pharmaceutical company policies where drugs may be replaced
free of charge if not used during time critical emergency situations (Fonarow,
Smith, Saver, Reeves, et al., 2011).
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Rapid access to intravenous tPA: The current stroke care system receives its drug
from the central pharmacy once the decision to infuse tPA has been made.
Changes to pharmacy protocol need to be considered where tPA will be stored in
the ER and can be accessed by the ER pharmacist during a stroke code.
Standardized order sets and dosing charts can be made available in the computer
Sunrise system to prevent dosing errors and facilitate timely administration of
tPA.



Team based approach: The interdisciplinary collaborative team needs to meet on a
monthly basis to discuss care quality, stroke performance improvement efforts,
patient safety and clinical outcomes. Recommendation for improvement and
monitoring can be made. Based on this study, the stroke alert time log can be
revised (Table 9), to include other key time factors such as time order for tPA
given, and time consent was signed. In order to ensure correct documentation of
time, an atomic time clock can be placed in all acute ER rooms as well at the
initial triage area. Staff need to be educated that only these clocks can be used for
time documentation.



Prompt data feedback: A data monitoring and feedback system needs to be
established where timely feedback can be provided on a patient by patient basis.
This will help the stroke team identify specific delays, set targets, and take
appropriate actions.

Furthermore, in-services and education of ER and other pertinent staff need to be
conducted so they perceive a stroke alert with the same sense of urgency as assigned to a cardiac
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alert or trauma alert. They need to realize that with each passing minute and activity, the brain is
dying and irrevocable damage is being done to millions of brain cells. It is also important to
acknowledge the fact that door to drug time of less than 60 minutes may not be achievable in all
patients presenting with acute ischemic stroke symptoms. Quality, safety and outcome data
needs to be regularly and closely monitored for any possible unintended consequences from
rushed assessments, dosing errors or complications. Taking into consideration these unavoidable
circumstances, the JC's target is to acheive a door to tPA time of less than 60 minutes in at least
≥ 80% of the patients presenting to a primary stroke center. Thrombolytics can be administered
in a safe and effective manner and timely administration can be a reality for majority of the
patients (Schwamm, Pancioli, Acker, Goldstein, et al., 2005).

52

Table 8: Revised Stroke Alert Time Log
Time

Event

…….

Time of arrival or time identified with stroke symptoms

…....

Time patient last seen normal

…….

Time stroke alert was called

…….

Time patient was first evaluated by a physician

…….

Time specimen was sent to lab

…….

Time order entered for CT scan

…….

Time CT done

…….

Time CT results called to physician

…….

Time labs results become available

.......

Time Tele-neuro System set up in patient room

……

Time neurologist consulted

…….

Time call returned by teleneurologist

.......

Time evaluation performed by teleneurologist

.......

Time order for tPA given

.......

Time consent for tPA signed

.......

Time tPA arrived from pharmacy

……

Time tissue plasminogen activator initiated

Note. CT = computerized tomography.
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Limitations
The study posed several challenges. First, the lack of adequate record keeping and loss of
records during the initial period of certification as a primary stroke center limited a complete
analysis of all patients who received tPA in the selected time frame. Second, the sample size was
small and limited extensive statistical analysis. Third, it would have been valuable to study other
key time factors such as time the drug was ordered and time the consent was signed, however,
these were not captured in the stroke log or medical record. Nevertheless, this study will serve as
a stepping stone to implement further quality initiatives and strategies in the care of a patient
presenting with acute ischemic stroke.

Future Research
The present study provides an opportunity for continued evaluation of quality
improvement and performance measures to ensure that acute ischemic stroke patients are treated
in a timely manner. Detailed data feedback, a patient focused organizational culture and
interdisciplinary team work will facilitate accountability and help achieve improvement in door
to tPA times. In addition to ongoing assessment and evaluation, time series analysis can also be
conducted to identify areas of potential delays. Other potential influences such as provider
specific delays, time of the week, time of the day can also be analyzed.

Summary
The therapeutic benefits of intravenous tPA is time dependent in an acute ischemic stroke
patient and is an important determinant of 90 day and one year functional outcomes. For every
15minute reduction to the start of reperfusion therapy, there is 5% lower odds of risk adjusted inhospital mortality. For every 10 minute delay to the start of reperfusion therapy, 20 million nerve
cells die and one fewer patient of 100 patients have improved functional outcomes. This has
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resulted in national organizations setting a target door to drug time of less than 60 minutes in
acute ischemic stroke patients. The study revealed that only 7.5 % eligible tPA patients received
the drug within 60 minutes of arrival, with shorter onset of symptoms to arrival time having
longer door to tPA time. These findings support the need to re-evaluate the stroke care process in
the ER, without compromising short term clinical outcomes. Organizational strategies and
clinical practice strategies discussed will have to be implemented to improve timely tPA
administration, thereby integrating evidence into clinical practice in the care of an acute ischemic
stroke patient.
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